Since then, Musk hasn’t hidden his anger with Altman and OpenAI. He’s currently suing the company over its decision to become a for-profit corporation, and he regularly trolls the company on X—the platform he bought for $44 billion back in 2022. All of which is why the past week has been hilarious.

Trump's inauguration drew several business and tech CEOs, including Jeff Bezos, Mark Zuckerberg, Elon Musk, Tim Cook, and TikTok's Shou Zi Chew.

Amazon founder Jeff Bezos has also adjusted his stance toward Trump. Despite a contentious history involving disputes over federal contracts and criticism of The Washington Post, Bezos has shown ...

OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan. Now, the startup is raising a $1 billion Series A that Altman is joining,

Sam Altman (@sama) January 17 ... Apple’s Tim Cook, and Amazon’s Jeff Bezos, who donated to the inaugural fund. All received a letter from Warren and Bennet. Some of the CEOs of those ...

Tesla CEO Elon Musk, Meta CEO Mark Zuckerberg, Amazon founder Jeff Bezos and OpenAI CEO Sam Altman will all attend President-elect Trump's inauguration, a source familiar with the planning who was ...

Top tech billionaires including some who were critics of Trump during his first term flock to his inaugural celebrations.

Open AI’s Sam Altman and TikTok CEO Shou Zi Chew were ... partially obscured) and Amazon's Jeff Bezos were spotted together at a pre-inauguration service at St. John's Church in Washington ...

Elon Musk has questioned the microchip claims made by DeepSeek AI, a fast-emerging player in the artificial intelligence pool, which is starting to challenge the United States' control over the AI industry. Newsweek has reached out to DeepSeek via email and Musk via X's press department for comment.

Donald Trump’s first week in office isn’t over yet, but what the Republican president has done so far offers clues about how his next four years in the White House may unfold.

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.

Donald Trump takes the oath as the 47th US president in a grand ceremony at Capitol Hill. Attended by global leaders, Trump vows major changes, including the largest deportation program, completing the border wall,